EL - EssilorLuxottica Société anonyme
PAR
->
Healthcare
->
Medical Instruments & Supplies
Paris,
France
Type: Equity
EL price evolution
EL
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $1752 | $1909 | $1452 | $1904 |
| Inventory | $2603 | $2863 | $2979 | $3097 |
| Total current assets | $8915 | $8585 | $9139 | $11247 |
| Long term investments | ||||
| Property, plant & equipment | $5039 | $4890 | $4976 | $4869 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $23283 | $22650 | $23415 | $22715 |
| Current liabilities | ||||
| Accounts payable | $1252 | $1257 | $1670 | $1520 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $6574 | $5914 | $6240 | $7700 |
| Long term debt | $6640 | $7088 | $7117 | $5128 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $17571 | $17308 | $17830 | $16838 |
| Shareholders' equity | ||||
| Retained earnings | $13858 | $13784 | $13991 | $14261 |
| Other shareholder equity | -$856 | -$1063 | $5585 | -$875 |
| Total shareholder equity | ||||
| (in millions $) | 30 Jul 2023 | 30 Jul 2022 | 29 Jul 2021 | 29 Jul 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $4958 | $5022 | ||
| Short term investments | ||||
| Net receivables | $1452 | $1629 | $1702 | $1194 |
| Inventory | $2979 | $2920 | $2505 | $2062 |
| Total current assets | $9139 | $9298 | $9768 | $8892 |
| Long term investments | ||||
| Property, plant & equipment | $4976 | $4599 | $2280 | $2055 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $12203 | $8889 | ||
| Total investments | ||||
| Total assets | $23415 | $20910 | $21971 | $17781 |
| Current liabilities | ||||
| Accounts payable | $1670 | $1822 | $1692 | $1177 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $6240 | $5815 | $5298 | $5179 |
| Long term debt | $7117 | $5144 | $5537 | $4914 |
| Total noncurrent liabilities | $10582 | $8640 | ||
| Total debt | ||||
| Total liabilities | $17830 | $15320 | $15880 | $13819 |
| Shareholders' equity | ||||
| Retained earnings | $13991 | $13912 | $12244 | $10134 |
| Other shareholder equity | $5585 | -$762 | -$436 | -$638 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4280 | $3518 | $3609 | $3755 |
| Cost of revenue | ||||
| Gross Profit | $3126 | $2448 | $2446 | $2596 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $2544 | $2349 | $2420 | $2281 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $195 | $10 | -$16 | $125 |
| Interest expense | -$58 | -$54 | -$46 | -$21 |
| Net income | ||||
| Net income | $313 | $31 | -$33 | $156 |
| Income (for common shares) | ||||
| (in millions $) | 30 Jul 2023 | 30 Jul 2022 | 29 Jul 2021 | 29 Jul 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $15910 | $17737 | $16215 | $14294 |
| Cost of revenue | ||||
| Gross Profit | $11346 | $13432 | $12381 | $10742 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $9575 | $9888 | $9763 | $10136 |
| Operating income | $2618 | $606 | ||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $387 | $628 | $456 | $350 |
| Interest expense | -$124 | -$136 | $173 | $161 |
| Net income | ||||
| Net income | $1006 | $2390 | $2870 | $684 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$557 | -$295 | -$3217 | -$527 |
| Financing activities | ||||
| Dividends paid | -$474 | -$236 | -$925 | -$687 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$489 | -$219 | $1590 | $1090 |
| Effect of exchange rate | $19 | -$17 | -$32 | -$6 |
| Change in cash and equivalents | -$90 | -$939 | $72 | $1574 |
| (in millions $) | 30 Jul 2023 | 30 Jul 2022 | 29 Jul 2021 | 29 Jul 2020 |
|---|---|---|---|---|
| Net income | $2875 | $696 | ||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $3631 | $2280 | ||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$3217 | -$945 | -$1864 | -$1698 |
| Financing activities | ||||
| Dividends paid | -$925 | -$840 | -$753 | -$503 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $1590 | -$3036 | -$1892 | $1461 |
| Effect of exchange rate | -$32 | -$60 | $61 | -$8 |
| Change in cash and equivalents | $72 | -$1001 | -$64 | $2035 |
News
|
New Strong Sell Stocks for March 4th
Zacks via Yahoo Finance
4 Mar 2024
|
|
Best Income Stocks to Buy for January 12th
Zacks via Yahoo Finance
11 Jan 2024
|
|
These 20 Countries Minted The Most New Billionaires in 2023
Insider Monkey via Yahoo Finance
5 Dec 2023
|
|
Meta & Ray-Ban’s New Smart Glasses Bring AI and AR Closer Together
Exec Edge via Yahoo Finance
12 Oct 2023
|
|
12 Stocks That Will Always Grow
Insider Monkey via Yahoo Finance
28 Aug 2023
|
|
25 Biggest Companies in Europe by Employees
Insider Monkey via Yahoo Finance
25 Apr 2023
|
|
15 Largest French Companies in the U.S.
Insider Monkey via Yahoo Finance
20 Apr 2023
|
|
Institutional investors own a significant stake of 44% in Mister Spex SE (FRA:MRX)
Simply Wall St. via Yahoo Finance
1 Jan 2023
|
|
The Zacks Analyst Blog Highlights: Home Depot, JD.com and EssilorLuxottica
Zacks via Yahoo Finance
30 Nov 2021
|
|
New Strong Sell Stocks for June 5th
Zacks via Yahoo Finance
25 Sep 2020
|
Fundamentals
| Market cap | $73.37B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 358.43M |
| Revenue | $15.16B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $467.00M |
| Revenue Q/Q | -7.38% |
| Revenue Y/Y | -7.31% |
| P/E ratio | 157.11 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 4.84 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $1.30 |
|---|---|
| ROA | 2.03% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.36 |
| Quick ratio | 0.96 |